Introduction Established in May 2011, Shanghai Haiyan Pharmaceutical Technology Co., Ltd. operates from Zhangjiang Pharma Valley in the Pudong New Area of Shanghai. As a wholly-owned subsidiary of the Yangtze River Pharmaceutical Group, the company dedicates its efforts to the research and development of Class 1 innovative chemical drugs. Its focus encompasses the advancement of treatments in areas such as oncology, neurology, immunology, and cardiology. |